Skip to content
Get the Balanced News app for a better experience!
The Balanced News Logo
Analytics
The Balanced News Logo

Stay Balanced, Stay Informed

Menu
  • Browse News
  • Underreported Stories
  • Curated Feeds
  • Insights
  • Analytics
  • Our Writers
  • About Us
  • Download App
Learn
  • How It Works
  • Bias Detection
  • Lens Score
  • Source Bias Checker
  • Accountability
  • Custom Feeds
Newsroom
  • Writers & Analysts
  • About TBN
  • Editorial Standards
  • Corrections Policy
  • Our Partners
  • Insights
Socials
  • Youtube
  • Instagram
  • X
  • Facebook
News Categories
  • Trending
  • Politics
  • Sports
  • Business
  • Tech
  • Entertainment
  • Health
  • Science
  • Crime
  • Lifestyle
  • National
  • International
  • Good News
  • Crypto

Get Our App

Available for iOS and Android


LensFeedsInsightsAnalyticsTrendingGood NewsSportsPoliticsBusinessCrimeTechEntertainmentHealthNationalInternational

© 2026 The Balanced News. All rights reserved.

About UsEditorial StandardsCorrectionsHelp & SupportPrivacy PolicyTerms & Conditions
Kapiva Partners with CCRAS to Commercialize Clinically Evaluated Ayurvedic Products

Categories

Categories

Related Coverage

Select a news story to see related coverage from other media outlets.

Related Coverage

Select a news story to see related coverage from other media outlets.

  1. Home
  2. /
  3. Business

Kapiva Partners with CCRAS to Commercialize Clinically Evaluated Ayurvedic Products

Analysed 17 Sept 2026·2 sources analysed·India·Business
Kapiva Partners with CCRAS to Commercialize Clinically Evaluated Ayurvedic ProductsPreviousNext

Kapiva, a science-backed Ayurvedic brand, has partnered with the Central Council for Research in Ayurvedic Sciences (CCRAS) under the Ministry of AYUSH to commercialize clinically evaluated Ayurvedic formulations. The collaboration grants Kapiva access to CCRAS's proprietary formulations and clinical data for 10 products targeting health areas like pain, stress, metabolic health, sleep, liver, and respiratory health. Kapiva will adapt these formulations into modern, consumer-friendly formats, conduct dose-equivalence studies if needed, and manage large-scale manufacturing and distribution nationwide.

Sentiment
75%
TBN's observations

First-hand measurement across 2 sources

We measured how 2 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is positive (75/100). Lens Score 44/100.

Outlets measured: thetribune, thetribune. See how each one headlined and framed the same story in the source comparison below.

AI analysis of 2 sources · Published under editorial oversight by The Balanced News
Analysed 17 Sept 2026· How this analysis is produced· Editorial standards· Corrections

AI Analysis

Sentiment — Positive (75/100)

Sentiment was consistent across outlets (75–75/100), indicating broadly factual reporting rather than editorialising.

Coverage timeline

thetribune broke this story on 17 Sept, 11:41 am. Other outlets followed.

17 Sept, 11:41 am2 sources · 50 min17 Sept, 12:31 pm
AI analysis by the TBN Bias Engine · beat methodology byMrunal Wange· Business & Economy Editor· editorial standards byOjas Kale
← Previous
Gateway to UAE Roadshow Highlights India's Shift to Regional Export Hubs
Next →
Clothing Businesses Urged to Plan Early for Late Diwali 2026 Festive Season
  • 1
    thetribune17 Sept, 11:41 am
    Kapiva Partners with Central Council for Research in Ayurvedic Sciences (CCRAS) to Commercialise Clinically Evaluated Ayurvedic Formulations - The Tribune
  • 2
    thetribune17 Sept, 12:31 pm
    Kapiva Partners with Central Council for Research in Ayurvedic Sciences (CCRAS) to Commercialise Clinically Evaluated Ayurvedic Formulations - The Tribune
  • Who's involved

    Institutions and figures named across source coverage.

    Government
    Central Council of Research in Ayurvedic SciencesCentral Council for Research in Ayurvedic SciencesMinistry of AYUSH, Government of IndiaMinistry of AYUSH
    Corporate
    Kapiva

    Story context

    Category
    Business
    Location
    India
    Sources analysed
    2
    Last analysed
    17 Sept 2026
    Key entities
    AyurvedaIndiaMinistry of AyushTechnology transferShelf lifeIntellectual propertyGovernment of IndiaLiverEcosystemMetabolismRespiratory systemPublic sector